Human Toll-like receptor 4 recognizes host-specific LPS modifications

被引:469
作者
Hajjar, AM
Ernst, RK
Tsai, JH
Wilson, CB
Miller, SI [1 ]
机构
[1] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA
[2] Univ Washington, Dept Immunol, Seattle, WA 98195 USA
[3] Univ Washington, Dept Pediat, Seattle, WA 98195 USA
[4] Univ Washington, Dept Med, Seattle, WA 98195 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1038/ni777
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Lipopolysaccharide (LPS) is the principal proinflammatory component of the Gram-negative bacterial envelope and is recognized by the Toll-like receptor 4 (TLR4)-MD-2 receptor complex. Bacteria can alter the acylation state of their LPS in response to environmental changes. One opportunistic bacterium, Pseudomonas aeruginosa, synthesizes more highly acylated ( hexa-acylated) LPS structures during adaptation to the cystic fibrosis airway. Here we show that human, but not murine, TLR4-MD-2 recognizes this adaptation and transmits robust proinflammatory signals in response to hexa-acylated but not penta-acylated LPS from P. aeruginosa. Whereas responses to lipid(IVA) and taxol are dependent on murine MD-2, discrimination of P. aeruginosa LPS structures is mediated by an 82-amino-acid region of human TLR4 that is hypervariable across species. Thus, in contrast to mice, humans use TLR4 to recognize a molecular signature of bacterial-host adaptation to modulate the innate immune response.
引用
收藏
页码:354 / 359
页数:6
相关论文
共 36 条
  • [1] Human MD-2 confers on mouse Toll-like receptor 4 species-specific lipopolysaccharide recognition
    Akashi, S
    Nagai, Y
    Ogata, H
    Oikawa, M
    Fukase, K
    Kusumoto, S
    Kawasaki, K
    Nishijima, M
    Hayashi, S
    Kimoto, M
    Miyake, K
    [J]. INTERNATIONAL IMMUNOLOGY, 2001, 13 (12) : 1595 - 1599
  • [2] Cutting edge: Cell surface expression and lipopolysaccharide signaling via the Toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages
    Akashi, S
    Shimazu, R
    Ogata, H
    Nagai, Y
    Takeda, K
    Kimoto, M
    Miyake, K
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 164 (07) : 3471 - 3475
  • [3] TLR4 mutations are associated with endotoxin hyporesponsiveness in humans
    Arbour, NC
    Lorenz, E
    Schutte, BC
    Zabner, J
    Kline, JN
    Jones, M
    Frees, K
    Watt, JL
    Schwartz, DA
    [J]. NATURE GENETICS, 2000, 25 (02) : 187 - +
  • [4] The innate immune system in cystic fibrosis lung disease
    Bals, R
    Weiner, DJ
    Wilson, JM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (03) : 303 - 307
  • [5] Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkp985, 10.1093/nar/gkh121, 10.1093/nar/gkr1065]
  • [6] Tlr4: central component of the sole mammalian LPS sensor
    Beutler, B
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2000, 12 (01) : 20 - 26
  • [7] Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis
    Burns, JL
    Gibson, RL
    McNamara, S
    Yim, D
    Emerson, J
    Rosenfeld, M
    Hiatt, P
    McCcoy, K
    Castile, R
    Smith, AL
    Ramsey, BW
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (03) : 444 - 452
  • [8] Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex - Transfer from CD14 to TLR4 and MD-2
    Correia, JD
    Soldau, K
    Christen, U
    Tobias, PS
    Ulevitch, RJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (24) : 21129 - 21135
  • [9] Cystic fibrosis
    Davis, PB
    Drumm, M
    Konstan, MW
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (05) : 1229 - 1256
  • [10] Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa
    Ernst, RK
    Yi, EC
    Guo, L
    Lim, KB
    Burns, JL
    Hackett, M
    Miller, SI
    [J]. SCIENCE, 1999, 286 (5444) : 1561 - 1565